Kevin F Mclaughlin Decibel Therapeutics, Inc. (DBTX) insider trading activity

Kevin F Mclaughlin is Director of Decibel Therapeutics, Inc.. Currently has a direct ownership of 0 shares of DBTX, which is worth approximately $0. The most recent transaction as insider was on Sep 25, 2023, when has been sold 5,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

KEVIN F MCLAUGHLIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Sep 25 2023	SELL Sale (or disposition) back to the issuer	-	5,000 Reduced 100.0%	0 Common Stock
Jun 13 2023	BUY Grant, award, or other acquisition	-	5,000 Added 50.0%	5,000 Common Stock

Also insider at

XLRN

ACCELERON PHARMA INC Healthcare

SVP, CFO and Treasurer

VCEL

Vericel Corp Healthcare

ADGI

Adagio Therapeutics, Inc. Healthcare

KFM